$%,-$.,-0!,(!#'/-,)+0&,%*,+,)0! Prof. Akira Kurosaka, Ph. D. @ ! ! ! Assist. Prof. Yoshiaki...

3

Click here to load reader

Transcript of $%,-$.,-0!,(!#'/-,)+0&,%*,+,)0! Prof. Akira Kurosaka, Ph. D. @ ! ! ! Assist. Prof. Yoshiaki...

Page 1: $%,-$.,-0!,(!#'/-,)+0&,%*,+,)0! Prof. Akira Kurosaka, Ph. D. @ ! ! ! Assist. Prof. Yoshiaki Nakayama, Ph. D. 76 ! @Û ( &/q $ý å k 9/q { © ê ê | Ç ³ × 7 « ª ëw z ^ y ±

��! �! �

����������"$%,-$.,-0!,(!#'/-,)+0&,%*,+,)0!

Prof. Akira Kurosaka, Ph. D. ŀ

��! �! ��!

Assist. Prof. Yoshiaki Nakayama, Ph. D.

76����!

ŀ ÛĨƙ�&/qƚĤýƗåąk�Ĺ/qƙ�ƑƔŻ

ƩǪƌƙ�ĚƚǪżƃƑƀƙLJƳǗƘ ķƆƫƪǫwźƚ

ŞŹƱDŽLjǢƹǠƻnjƿǛǥŁŘťŭŞŒŦłǪǚǥǐǧǃǨŝťůǩǪ

ŻƪżƚǴŹƱDŽLjǢƼǢƾƿǛǥŁŘŭŦŞŒŦłƕLJǥǒƻĐ

�ƙDŽǡǥǪnjǣƷǏǥ¢HƙǓǍǤƺǁǢHƕƙīƘi

vƆƫƪ şŹƼǡƾǁǍEâ5ǨŘťŭŞŒŦαňŸŢŨŲņţūŲŃŀ

ŝťůαňŸŢŨŲņţūŲŃŀ ŘŭŦŞŒŦβňŸŢŨŲņţūŲǩƮ�ƑÛĨƘ

§ÆƇǪƌƫƨƙ�ƘëƘſƄƪ�êƮĂ�ƇƓżƪǫƅ

ƙ�Ɣ ŘťŭŞŒŦαňŸŢŨŲņţūŲ ƙÛĨƚǪÙrLJǥǒƻĐ

ƔŻƪǜLjǥƘNƃþƨƫƪƅƕƀƨǪǜLjǥEÛĨƕƤ9

ƛƫƪǫŀ

ŀ ǜ Lj ǥE Û Ĩ ƙ5vĪQ/q ƚÛēÐĢÞ

ŤŕŠńŘťŭŞŒŦőŀ űŰŭŶűŨűŴŬŧŨŀ ŞńťŦŨŴŶŭŪťŭťŦŴŰųťŮŬůŶŭńŀ

ŴŲťůųũŨŲťųŨŀ Ł į ŘťŭŞŒŦńţłƘƧƩăSƆƫƪŅŀ ƅƙĢ

ÞƚǓnjƘſżƓƚ ʼnŇ ÑķƀƨvƪOƂƗĞ�TǕưǛǡ

ǧƮivƉƪǫwźƚƅƫƠƔƘǪÎá³½ÄƘöƉ

ƪ ŘťŭŞŒŦńţŐǪńǵňŎ Ʈ,IJƇƍǫƅƙ ʼn ƑƙƱƳdžǀƳ

ǜƚǪĢÞ¨rƘĬƭƪǞLjǧǕ�ƘL½Ʈ�ƏǪŬůŀ

ŵŬŴŲŰ ƔƙĢÞ¨rƁƟƕƯƖ��ƔƂƗżǪƿǖǕưǛǡ

ǧƘ_ƉƪǫwźƚǪŀ şńƼǡƾǁǍEÛĨǪſƧƜƌƙ

5vĢÞƙ�ƘëƘſƄƪ�êĂ�ƮÆÄƕƇƓǪ 

ƙƧŽƗċĶƘ0ƩàƯƔżƪǫŀ ŀ

ň ł ŀŘť ŭŞŒŦńţňŎ ƙ�êĂ�ŀ

ŀ wźƚŀ ŘťŭŞŒŦńţňŎ ƁǪv�ƙëƘſżƓƚªļƥ

ĀeŃŀ ]ëƙÎáßéƘhƃöƇǪÎá *ƘĬƭ

ƪƅƕǪƠƍƗGĺßéƮºżƍXĽƔƚ ŘťŭŞŒŦńţňŎ

ƁƶǥǍƿƳnjǧǁǃáĒƮČ×ƇƓżƪ2êrƤþżƎ

Ƈƍǫŀ�dfƚǪŘťŭŞŒŦńţňŎ ƙĞ�T��ǚƴǃƮ�

üƇƓƌƙ�êƮĂ�Ƈƍǫŀ

ǭł ŀ DžǖǠǕƲljǁǟƮºżƍ ŘťŭŞŒŦńţ ǕưǛǡǧƙŀ

ŀ ŀ �êĂ�ŀ

ŀ ĢÞ¨rƁ��ƔƂƊ¸*VÄƗĂ�ƁAijƗƿǖ

ǕưǛǡǧƮ�ƗLJǧƽljnjƇƓǪDžǖǠǕƲljǁǟƮºżƓ

öĂ�ǪſƧƜ�êĭYXĽƮ÷ƐƓƂƍǫ�df

ƚǪƽǐǜãı|øƔŻƪ ţŒŜŖŞ ¦ƥ ŔšŚŢŠšņŔťų ǁ

ǃNJǜƮºżƓǪL½��üƮćơƍǫŀ

Ǯǩŀ ŠňŐèrìÂßéƮºżƍ�ÿÎá *ǞNjŀ

ŀŀ ŀ ŀǢƙËÔŀ

ŀ Îáßéƙ�êƥ *ƙĂ�ÖƘºżƨƫƪǪN

*êƮ�Ɖƪǚƴǃèrì¼� ŠňŐ ßéƚǪǣLjǐƳ

ǥģUB�Ɣ©ĜGĺƉƪƅƕƔǪÎáǪſƧƜƼǡƱ

ßéƝƕ *ƉƪǫƇƀƇƅƙ�¦ƔƚǪĴÎáÜßé

ƁK£ƉƪƅƕǪv±ƇƍÎáßéƝƙ *Ƙĩ�ī

ƙGĺƁpýƔŻƪÖƙ=Ķ¯ƁŻƐƍǫwźƚǪ�È

GĺÜƘÎá *ƘĬƭƪ@TƮ&žƓGĺƉƪƅƕ

ƔǪŠňŐ ßéƮÉ�īƔ(µƧƃÎáßéƝƕ *ƆƋ

ƪ�Ƙv%Ƈƍǫŀ

ǯǩƌƙƙşńƼǡƾǁǍEÛĨƙ�êĂ�ŀ

ŀ ŀ ǜLjǥEÛĨƙĂ�Ƙ&žƓǪwźƚßéMƔö

Ɖƪ�ÿ şńƼǡƾǁǍEÛĨƙ�êƮǪDžǖǠǕƲljǁǟ

ƮºżƓČƞƍǫŀ

ŀ

86���4�� �!

ňł ŀŘť ŭŞŒŦńţňŎ Ğ�T��ǚƴǃƙĂ�ŀ

ŀ wźƚ ŘťŭŞŒŦńţňŎ ƙ�êĂ�ƙƍƣŃŘťŭŞŒŦńţňŎ

Ğ�T��ǚƴǃƮ�üƇƍǫƅƙĞ�T��ǚƴǃƚ

�Ĥ­^ƙÁ´ƮÌƇŃŀ ĥ¸Eǚƴǃƕ¥ĔƇƓ�ĸ

ĦƁ­^ƇƓżƍǫƅƙĞ�TƙöĵFƙĈßƗĂ

�Ʈ÷ƐƍƕƅƬŃĄuƮ4ƪªļƥz��ĵFƘhż

öƁĉƣƨƫƍƘŃ®í��ƕƇƓ�ƃĀe�ğƙ

í���ƔöƇƓżƍŀ ŁŗŬŪŅŀ ňłŀ ǫƅƫƨƙâ�ƀ

ƨŃŘťŭŞŒŦńţňŎ Ɓ®í��ƘſżƓ�ĸ÷)Ʈ¡Ƙ#

oƇƓżƪƅƕƁÌ<Ɔƫƍǫŀ

ʼnł ŀţŒŜŖŞŃŀŔšŚŢŠšņŔťų ǁǃNJǜƮºżƍDžǖǠǕŀ

ŀ ŀ Ʋljǁǟ ŘťŭŞŒŦńţ ǕưǛǡǧL½�ƙ�üŀ

ŀ wźƁƅƫƠƔƘ,IJǦ6WƇƍDžǖǠǕƲljǁǟ

ŘťŭŞŒŦńţ ƱƳdžǀƳǜƙŽƏƔŃŀ ³Ƙƌƙ�êƁ ƀƐ

ƓżƗż ŘťŭŞŒŦńţ ƘƑżƓŃŀ ƽǐǜãı|øƔŻƪ

!

! Fig. 1

Page 2: $%,-$.,-0!,(!#'/-,)+0&,%*,+,)0! Prof. Akira Kurosaka, Ph. D. @ ! ! ! Assist. Prof. Yoshiaki Nakayama, Ph. D. 76 ! @Û ( &/q $ý å k 9/q { © ê ê | Ç ³ × 7 « ª ëw z ^ y ±

ţŒŜŖŞ ¦ƥ ŔšŚŢŠšņŔťų ǁǃNJǜƮºżƓǪƌƙL½

��üƮćơƍǫƅƫƠƔƘ ŘťŭŞŒŦńţŐ ƥńţňŏ Ƙ[Ɖ

ƪ ţŒŜŖŞ ǘƻLJǧǪŔšŚŢŠš ǘƻLJǧƮ�ØƇǪDžǖǠǕ

Ʋljǁǟ1Ú-Ƙ�ĝrƘöƆƋƍƕƅƬǪ�Äġ!

ƘL½Ʈ\�ƉƪƅƕƘv%ƇƓżƪǫŀ

Ŋǩŀ ŠňŐ èrìÂßéƮºżƍ�ÿÎá *ǞNjŀ

ŀ ŀ ǢƙËÔŀ

ŀ ŀ ŠňŐ ßéƙm�ƙ *�¦ƚǪǣLjǐƳǥģUB�

Ɣ©ĜGĺƇǪßé�ıIƮivƆƋƪ�¦Ɓºżƨ

ƫƓƂƍǫƇƀƇƅƙ�¦ƔƚǪĴÎáÜßéƁK£Ɖ

ƪƅƕǪv±ƇƍÎáßéƝƙ *Ƙĩ�īƙGĺƁ

pýƔŻƪÖƙ=Ķ¯ƁŻƐƍǫwźƚǪ©ĜGĺƁĴ

ÎáßéƙK£ƙ.@ƕæžǪ�ÈGĺƮH�ƕƇƍ

É�īƔ(µƙðżÎáßé *ÜƮËÔƇƍǫƅƫ

ƠƔƙÎáßé *ƘĬƭƪ@TƙÊÒƘHƒƂǪŁŬłŀ

ǠǛǏǥƮƾǧnjƇƍGĺÅ�Ɣ,`GĺƉƪǪŁŬŬłŀ Ƴǥ

ǃǡǥƥnjǠǥǃǕƵǡǥÖƙÎá *@TƮ8Ƣ°ö¬

GCƮºżƪǪŁŬŬŬłŀ ǣLjǐƳǥģƘ&žƓǪǐljLjǁƼǎ

ǢĭY$ƔŻƪ ŕŒŠţ Ʈ«&ƉƪǪŁŬŵłŀ *ƙ"�¤

İƘ ŗŘŗŏ Ʈ«&ƉƪÖƙ��ƮƕƩ�ƫƍǫƌƙâ�Ǫ

*Ċ\ĪQk Ŋ�ŋ �ÆƘÎáÓđƙivǪō �Æ

ƘƚƧƩ¨ÃƗÓđ�gƁāZƆƫƍǫ�¿�ñƥƸǢ

ǁƴǜƳǝǧǂǥƼƗƖƘƧƪĂ�ƘƧƩǪō �ÆƔïj

ÄƗÎá¨)Ʈ�Ƈƍv±ÎáßéƝƙ *Ɓĉƣƨ

ƫƪ��ƔǪƼǡƱßéƚUBƇƗƀƐƍǫ �ƧƩǪ�

Ƈż�¦ƔƚǪŠňŐ ßéƚm�ƙÝ+ �ƙ�īƔǪ

(µƧƃÎáßéƘƙơ *ƉƪƅƕƁ�ƨƀƕƗƐƍǫŀ

ǯǩƌƙƙşńƼǡƾǁǍEÛĨƙ�êĂ�ŀ

ŀ ßéMƔöƉƪ�ÿ şńƼǡƾǁǍEÛĨƙ�êƮǪ

DžǖǠǕƲljǁǟƮºżƓČƞƍǫwźƚƅƙÛĨ�Ěƙ

5vƘĬƭƪÛēÐĢÞƁ"�èƘſżƓëƘhƃÃ

¶ƉƪƅƕƮþżƎƇƍǫƠƍǪ�ĢÞƙöƮ}#Ɖƪ

ƕǪëƘſżƓit½cƮ¸ƈƪƙƘ[ƇǪƙàäƔ

ƙù¶EƙL*ƚāZƆƫƗƀƐƍǫƅƙ�ƀƨǪƅƙ

ĢÞƁ�ƘëƘſżƓ�êƉƪ�ƁÌ<Ɔƫƍǫŀ

ŀ

�Research projects and annual reports We have been investigating roles of O-linked sugar chains with the linkage structures, GalNAcα1→Ser(Thr), Manα1→Ser(Thr), or GlcNAcβ1→Ser(Thr). O-GalNAc-type sugar chains are called mucin-type carbohydrates and their biosynthesis is initiated by a group of enzymes, UDP-GalNAc: polypeptide N-acetyl- galactosaminyltransferases (GalNAc-Ts). GalNAc-Ts consist of a large gene family with 20 isozymes in humans. Interestingly, GalNAc-T8, -T9, -T17, and

-T18 are catalytically inactive, while GalNAc-T9 and -T17, which were identified by us, are brain-specific and biologically important for the neural differentiation. Based on these backgrounds, we have focused on the functions of glycosyltransferases to make O-glycan carbohydrate-linkage structures, and obtained the following findings. 1) Analysis of mice defective of a GalNAc-T17 gene We found that GalNAc-T17 KO mice showed decreased body weight compared with wild-type mice (Fig. 1). Analysis of GalNAc-T17 expression demonstrated that it was expressed not only in hippocampus and amygdala, but in ventromedial nucleus of hypothalamus, which is known as satiety center. GalNAc-T17 may therefore positively regulate feeding behavior. 2) Production of zebrafish GalNAc-T mutants To produce zebrafish mutants defective of GalNAc-T genes, we employed recently developed genome-editing technology, TALEN and CRISPR/Cas systems. We found that mutations were successfully introduced at the target sites in the zebrafish embryos using TALEN and CRISPR/Cas vectors for GalNAc-T9 and -T18. 3) A rapid and efficient method for neuronal induction of P19 embryonic carcinoma cell line We revised a novel method to efficiently differentiate P19 cells into neurons by an adherent culture in laminin-coated dish in the presence of several reagents to induce neural differentiation and suppress growth of non-neural cells. The new method induced neurons within 4 days without gliogenesis. The mature neurons obtained were responsive to several neurotransmitters with functional neuronal networks. 4) Analysis of extracellular O-glycosylation We investigated the function of a glycosyltransferase in zebrafish, which catalyzes extracellular novel O-glycosylation. We found that it was strongly expressed in the brain of zebrafish embryos, and its suppression caused alterations in the brain development. 96��5��32!

Y. Nakayama, A. Wada, R. Inoue, K. Terasawa, I. Kimura, N.

Nakamura, A. Kurosaka: A Rapid and Efficient Method for

Neuronal Induction of the P19 Embryonic Carcinoma Cell Line.

Journal of Neuroscience Methods, in press.

Page 3: $%,-$.,-0!,(!#'/-,)+0&,%*,+,)0! Prof. Akira Kurosaka, Ph. D. @ ! ! ! Assist. Prof. Yoshiaki Nakayama, Ph. D. 76 ! @Û ( &/q $ý å k 9/q { © ê ê | Ç ³ × 7 « ª ëw z ^ y ±

M. Ogawa, N. Nakamura, Y. Nakayama, A. Kurosaka, H. Manya,

M. Kanagawa, T. Endo, K. Furukawa, T. Okajima: GTDC2

modifies O-mannosylated ŷ-dystroglycan in the endoplasmic

reticulum to generate N-acetyl-glucosamine epitopes reactive

with CTD110.6 antibody. (2013) Biochem Biophys Res

Commun 440(1), 88-93

I. Kimura, Y. Nakayama, Y. Zhao, M. Konishi, N. Itoh:

Neurotrophic effects of neudesine in the central nervous system.

(2013) Front Neurosci 7 (article111), 1-5

Y. Nakayama, N. Nakamura, D. Tsuji, K. Itoh, A. Kurosaka:

Genetic diseases associated with protein glycosylation

disorders in mammals. pp. 244-269 in Genetic Disorders,

Maria Puiu (Ed.), ISBN: 978-953-51-08866-3, InTech.

ŀ

:6���32ŀ

�a>�, :»ŻƦơ, ��Ç, ĿD�ǰ P19ǚƴǃèrì

Âßé�ƮºżƍĖęƀƑ(µƙðżÎáĊ\¦ƙËÔ.

Õ36?�� T¸²V�d�ǪÎybǪ2013.12.3-6

Y. Nakayama, K. Kato, N. Nakamura, A. Kurosaka: The roles

of a putative polypeptide GalNAc-transferase/Wbscr17.

International Symposium on Glyco-Neuroscience, Awaji city

(Japan) 2014.1.9-11

ŀ

;614�����!

Ǭǩŀ Mğďħ ¹Vě��6ÊÒǨƳǥLJǧǗǤNJƳǥÍǩŀ

ċĶ7ǰǶDZdzDzǁǃNJǜČ×õƙǃƻǡǧǏǥƼÜƘĬƉƪÊ

Òŀ

ÊÒ�ùçǰĿDŀ �Ǫ0ndfǰřʼnŌ dǨň dǩŀ

ŀ

VøÊÒ'vHħ'vħǦ�xÄôòÊÒŀ

ċĶ7ǰǞNjǢ¸²Ʈ¨ºƇƍ�PrëÀsĬěƷǧǕưǥ

ÛēÐĢÞƙ�êĂ�ŀ

ÊÒ ~çǰĿDŀ �Ńŀ 0ndfǰřʼnŌńʼnō dŀ Łʼn dłŀ

ŀ

ÏVÊÒĎû'ħǦ�VøĵFǪÎáÛĨ¸²Vŀ

ċĶ7ǰÎá?ĒivƘſƄƪǜLjǥEÛĨƘƧƪ�ƍƗî

ĕĘ#oǁǃNJǜƙĂ�ŀ

ÊÒ�ùçǰ�a>�Ńŀ 0ndfǰřʼnŋńʼnŌ dŀ Łʼn dłŀ

ŀ

VøÊÒ'vHħ'vħǦó{ÊÒŁœłŀ

ċĶ7ǰ��ĺ·J�ƙìÂßéƘſƄƪǚƻǤǔǐƿƳnjǧ

ǁǃƙ�êĂ�ŀ

ÊÒ�ùçǰ�a>�Ńŀ 0ndfǰřʼnŌńʼnō dŀ Łʼn dłŀ

ŀ

ǭǩŀ VM¨)ŀ ŀ

ĿDŀ �ǰ��¸*V�Ćč;Ǫ��õV�ė¾�ğR;ŀ

ŀ

Ǯǩŀ ƌƙŀ

ĿDŀ �ǰśŢŤ ƿƳƶǥǃƾǧǃǨ�Ġ¹�OVĮ_ľ�¸l

Ƙ ŘŗŠ ƙöƕÚüXĽƮ÷ƐƍǫǩǨʼnŇňŊŅŎŅʼnōǩǫŀ

ŀ

ŀ

ǠǙǝǥǑǧŀ ňŌ 3ĻúƘƓŀ